Who are we?
CRU is working with experienced, well trained full time staff of 43 people in Hungary and over 20 part-time employees, subcontractors in 7/24.
High quality performance is managed by a dedicated Quality management team and proved by 2 FDA, 6 local regulatory inspections and over 50 Sponsor and CRO audits.
CRU’s current core focus is the early phase studies with healthy volunteers or with special patient populations, eg. Renal impairment, hepatic impairment, rheumatology, pulmonology indications.
CRU Hungary is part of a CRU Global network and will initiate 2 new academic partner sites in 2023 in Budapest.